Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - hydrocortisone acetate, quantity: 10 mg/g - cream - excipient ingredients: chlorocresol; white soft paraffin; liquid paraffin; purified water; cetostearyl alcohol; cetomacrogol 1000 - topical corticosteroid therapy for non-infective inflammatory conditions of the skin eg. eczema, dermatitis.

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

organon pharma pty ltd - betamethasone valerate, quantity: 0.244 mg/g (equivalent: betamethasone, qty 0.2 mg/g) - cream - excipient ingredients: liquid paraffin; purified water; chlorocresol; cetostearyl alcohol; phosphoric acid; monobasic sodium phosphate dihydrate; cetomacrogol 1000; sodium hydroxide; white soft paraffin - antroquoril is indicated for maintenance therapy for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses such as atopic eczema, infantile eczema, nummular eczema, anogenital and senile pruritis, contact dermatitis, seborrhoeic dermatitis, neurodermatitis, solar dermatitis, statis dermatitis and psoriasis. indications as at 16 august 1999: antroquoril is indicated for maintenance therapy for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses such as atopic eczema, infantile eczema, nummular eczema, anogenital and senile pruritus, contact dermatitis, seborrhoeic dermatitis, neurodermatitis, solar dermatitis, stasis dermatitis and psoriasis

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

leo pharma pty ltd - methylprednisolone aceponate, quantity: 1 mg/g - cream - excipient ingredients: butylated hydroxytoluene; purified water; hard fat; cetostearyl alcohol; glyceryl monostearate; glycerol; disodium edetate; peg-40 stearate; benzyl alcohol; decyl oleate; medium chain triglycerides - topical treatment of eczema and psoriasis.

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

inova pharmaceuticals (australia) pty ltd - tretinoin, quantity: 0.5 mg/g - cream - excipient ingredients: cetyl alcohol; isopropyl palmitate; self-emulsifying glyceryl monostearate; sorbitan monostearate; polysorbate 60; dl-alpha-tocopheryl acetate; disodium edetate; propylene glycol; diazolidinyl urea; methyl hydroxybenzoate; propyl hydroxybenzoate; purified water; retinol palmitate - retrieve is indicated for the adjunctive treatment of dry photoaged skin and related conditions.

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - betamethasone valerate, quantity: 0.61 mg/g (equivalent: betamethasone, qty 0.5 mg/g) - cream - excipient ingredients: cetomacrogol 1000; cetostearyl alcohol; white soft paraffin; liquid paraffin; purified water; chlorocresol; monobasic sodium phosphate; phosphoric acid; sodium hydroxide - indications as at 23 april 2004 : eczema including : atopic, infantile, stasis and discoid eczemas. besnier's (flexural) prurigo. otitis externa. neurodermatoses including lichen simplex, lichen planus. seborrheic dermatitis, contact sensitivity reactions and allergies.

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

ego pharmaceuticals pty ltd - hydrocortisone, quantity: 10 mg/g - cream - excipient ingredients: benzyl alcohol; cetostearyl alcohol; cetomacrogol 1000; macrogol 400; cetyl alcohol; propylene glycol; purified water; glyceryl monostearate - egocort cream 1% is indicated for topical application for adjunctive therapy and symptomatic relief of inflammation associated with acute and chronic corticosteroid responsive conditions. this includes dermatitis, eczema and psoriasis.

Regne Unit - anglès - MHRA (Medicines & Healthcare Products Regulatory Agency)

ennogen healthcare ltd - lidocaine - cutaneous cream - 40mg/1gram

Regne Unit - anglès - MHRA (Medicines & Healthcare Products Regulatory Agency)

colorama pharmaceuticals ltd - lidocaine - cutaneous cream - 40mg/1gram

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

organon pharma pty ltd - betamethasone dipropionate, quantity: 0.64 mg/g (equivalent: betamethasone, qty 0.5 mg/g) - cream - excipient ingredients: phosphoric acid; cetostearyl alcohol; white soft paraffin; sodium hydroxide; cetomacrogol 1000; purified water; liquid paraffin; chlorocresol; monobasic sodium phosphate dihydrate - topical treatment of corticosteroid-responsive dermatoses. these include atopic eczema, infantile eczema, nummular eczema, contact dermatitis, neurodermatitis, anogenital and senile pruritus, lichen planus, intertrigo and psoriasis. indications as at 26 august 1992: eleuphrat is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. these include atopic eczema, infantile eczema, nummular eczema, contact dermatitis, neurodermatitis, anogenital and senile pruritus, lichen planus, intertrigo and psoriasis.

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

haleon australia pty ltd - hydrocortisone, quantity: 1 % w/w; clotrimazole, quantity: 1 % w/w - cream - excipient ingredients: cetomacrogol 1000; purified water; lactic acid; chlorocresol; cetostearyl alcohol; white soft paraffin; sodium hydroxide; glycerol; propylene glycol; light liquid paraffin - for dermatophyte and yeast infections of the skin when inflammation is prominent. this includes conditions such as fungal infected dermatitis, intertrigo and candida nappy rash.